CSIMarket
 


Mymd Pharmaceuticals Inc   (MYMD)
Other Ticker:  
 

Cumulative Mymd Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

MYMD's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

MYMD Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -15.42 % -33.36 % -33.27 % -37.86 % -29.22 %
Y / Y Total Liabilities Growth 243.66 % 384.25 % 530.53 % 173.98 % -11.5 %
Leverage Ratio for Trailing Twelve Months Period 0.72 0.6 0.37 0.14 0.11
Total Ranking # 1323 # 1234 # 877 # 418 # 307
Seq. Equity Growth 44.3 % -17.96 % -10.89 % -19.82 % 13.7 %
Seq. Total Liabilities Growth -56.19 % -5.31 % 464.03 % 46.88 % -38.27 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite debt repayement of -56.19% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.72, a new company high.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in In Vitro & In Vivo Diagnostic Substances industry 3 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Mymd Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are MYMD's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 4
Sector # 395
S&P 500 # 830


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.72 0.26 0.08
(Sep 30 2023)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Leverage Ratio for Trailing Twelve Months Period
Lantheus Holdings Inc   1.26 
Oncocyte Corporation  1.19 
Quidelortho Corp  0.76 
Immucell Corp  0.56 
Myriad Genetics Inc   0.47 
Alpha Teknova Inc   0.47 
Neogen Corporation  0.43 
Mymd Pharmaceuticals Inc   0.43 
Heska Corporation  0.39 
Biomerica Inc   0.28 
Meridian Bioscience Inc   0.26 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com